HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chen, Sheng ^a   Zhang, Min ^a   Xing, Lili ^a   Wang, Yue ^a   Xiao, Yongtao ^b   Wu, Yeming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute for Pediatric Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; ONCOPROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER GRADING; CELL MOTION; DISEASE MODEL; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ERINACEIDAE; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEDGEHOG PROTEINS; HETEROGRAFTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHATIC METASTASIS; MICE; NEOPLASM GRADING; NEOPLASM STAGING; NEUROBLASTOMA; ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR BURDEN; ZINC FINGER PROTEIN GLI1;

EID: 84926384295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121115     Document Type: Article

References (38)

1. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007; 67: 976-983. PMID: 17283129
2. Malek MM, Shah SR, Atri P, Paredes JL, Dicicco LA, Sindhi R, et al. Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation. Surgery. 2010; 148: 778-782. doi: 10.1016/j.surg.2010.07.021 PMID: 20728194
3. Gleason JM, Lorenzo AJ, Bowlin PR, Koyle MA. Innovations in the management of Wilms' tumor. Ther Adv Urol. 2014; 6: 165-176. doi: 10.1177/1756287214528023 PMID: 25083165
4. Vora A. Acute lymphoblastic leukemia: optimizing treatment strategies in children. Paediatr Drugs. 2002; 4: 405-416. PMID: 12038876
5. Ji RC. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Lett. 2014; 346: 6-16. doi: 10.1016/j.canlet.2013.12.001 PMID: 24333723
6. Semenza GL. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today. 2007; 12: 853-859. PMID: 17933687
7. Gilkes DM, Semenza GL. Role of hypoxia-inducible factors in breast cancer metastasis. Future Oncol. 2013; 9: 1623-1636. doi: 10.2217/fon.13.92 PMID: 24156323
8. Ghattass K, Assah R, El-Sabban M, Gali-Muhtasib H. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy. Curr Cancer Drug Targets. 2013; 13: 670-685. PMID: 23687923
9. Wang Q, Hu DF, Rui Y, Jiang AB, Liu ZL, Huang LN. Prognosis value of HIF-1α expression in patients with non-small cell lung cancer. Gene. 2014; 541: 69-74. doi: 10.1016/j.gene.2014.03.025 PMID: 24631267
10. Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, et al. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. Swiss Med Wkly. 2013; 143: w13855. doi: 10.4414/smw.2013.13855 PMID: 24018850
11. Chen J, Li T, Liu Q, Jiao H, Yang W, Liu X, et al. Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis. PLoS One. 2014; 9: e91842. doi: 10.1371/journal.pone.0091842 PMID: 24647137
12. Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T, et al. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer. Int J Clin Oncol. 2012; 18: 293-304. doi: 10.1007/s10147-012-0378-8 PMID: 22350022
13. Sun G, Wang Y, Hu W. Correlation between HIF-1α expression and breast cancer risk: a meta-analysis. Breast J. 2014; 20: 213-215. doi: 10.1111/tbj.12238 PMID: 24475904
14. Marton I, Knezevic F, Ramic S, Milosevic M, Tomas D. Immunohistochemical expression and prognostic significance of HIF-1α and VEGF-C in neuroendocrine breast cancer. Anticancer Res. 2012; 32: 5227-5232. PMID: 23225420
15. Choy SW, Cheng SH. Hedgehog signaling.Vitam Horm. 2012; 88: 1-23. doi: 10.1016/B978-0-12-394622-5.00001-8 PMID: 22391297
16. Efroni S, Meerzaman D, Schaefer CF, Greenblum S, Soo-Lyu M, Hu Y, et al. Systems analysis utilising pathway interactions identifies sonic hedgehog pathway as a primary biomarker and oncogenic target in hepatocellular carcinoma. IET Syst Biol. 2013; 7: 243-251. PMID: 24712101
17. Onishi H, Katano M. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer. World J Gastroenterol. 2014; 20: 2335-2342. doi: 10.3748/wjg.v20.i9.2335 PMID: 24605030
18. Matsushita S, Onishi H, Nakano K, Nagamatsu I, Imaizumi A, Hattori M, et al. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer. Cancer Sci. 2014; 105: 272-280. doi: 10.1111/cas.12354 PMID: 24438533
19. Huang L, Walter V, Hayes DN, Onaitis M. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer. Clin Cancer Res. 2014; 20: 1566-1575. doi: 10.1158/1078-0432.CCR-13-2195 PMID: 24423612
20. Mao L, Xia YP, Zhou YN, Dai RL, Yang X, Duan SJ, et al. A critical role of Sonic Hedgehog signaling in maintaining the tumorigenicity of neuroblastoma cells. Cancer Sci. 2009; 100: 1848-1855. doi: 10.1111/j.1349-7006.2009.01262.x PMID: 19622100
21. Shahi MH, Schiapparelli P, Afzal M, Sinha S, Rey JA, Castresana JS. Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors. Tumour Biol. 2011; 32: 113-127. doi: 10.1007/s13277-010-0105-x PMID: 20830616
22. Wickström M, Dyberg C, Shimokawa T, Milosevic J, Baryawno N, Fuskevåg OM, et al. Targeting the Hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer. 2013; 132: 1516-1524. doi: 10.1002/ijc.27820 PMID: 22949014
23. Spivak-Kroizman TR, Hostetter G, Posner R, Aziz M, Hu C, Demeure MJ, et al. Hypoxia triggers hedge-hog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013; 73: 3235-3247. doi: 10.1158/0008-5472.CAN-11-1433 PMID: 23633488
24. Bernhart E, Damm S, Wintersperger A, DeVaney T, Zimmer A, Raynham T, et al. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. Exp Cell Res. 2013; 319: 2037-2048. doi: 10.1016/j.yexcr.2013.03.029 PMID: 23562655
25. Li L, Li B, Zhang H, Bai S, Wang Y, Zhao B, et al. Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci. 2011; 52: 8393-8400. doi: 10.1167/iovs.11-8139 PMID: 21948554
26. Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responsesto gamma-radiation. Clin Cancer Res. 2005; 11: 4479-4486. PMID: 15958633
27. Kumar R, Knick VB, Rudolph SK, Johnson JH, Crosby RM, Crouthamel MC, et al. Pharmacokinetic-pharmacodynamic relationship from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol Cancer Ther. 2007; 6: 2012-2021. PMID: 17620431
28. Bijlsma MF, Groot AP, Oduro JP, Franken RJ, Schoenmakers SH, Peppelenbosch MP, et al. Hypoxia induces a hedgehog response mediated by HIF-1alpha. J Cell Mol Med. 2009; 13: 2053-2060. doi: 10.1111/j.1582-4934.2008.00491.x PMID: 18774959
29. Li W, Chen YQ, Shen YB, Shu HM, Wang XJ, Zhao CL, et al. HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo. Int J Mol Med. 2013; 32: 271-280. doi: 10.3892/ijmm.2013.1405 PMID: 23732337
30. Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F, et al. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol. 2003; 162: 1283-1291. PMID: 12651620
31. Jing SW, Wang YD, Chen LQ, Sang MX, Zheng MM, Sun GG, et al. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation. Dis Esophagus. 2013; 26: 75-83. doi: 10.1111/j.1442-2050.2011.01321.x PMID: 22340517
32. Guo M, Cai C, Zhao G, Qiu X, Zhao H, Ma Q, et al. Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma. PLoS One. 2014; 9: e90518. doi: 10.1371/journal.pone.0090518 PMID: 24618817
33. Hong SS, Lee H, Kim KW. HIF-1alpha: valid therapeutic target for tumor therapy. Cancer Res Treat. 2004; 36: 343-353. doi: 10.4143/crt.2004.36.6.343 PMID: 20368827
34. Acker T, Plate KH. Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology. Cancer Treat Res. 2004; 117: 219-248. PMID: 15015563
35. Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest. 2013; 123: 3664-3671. doi: 10.1172/JCI67230 PMID: 23999440
36. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3: 721-732. PMID: 13130303
37. Choi JY, Jang YS, Min SY, Song JY. Overexpression of MMP-9 and HIF-1α in breast cancer cells under hypoxic conditions. J Breast Cancer. 2011; 14: 88-95. doi: 10.4048/jbc.2011.14.2.88 PMID: 21847402
38. Schiapparelli P, Shahi MH, Enguita-Germán M, Johnsen JI, Kogner P, Lázcoz P, et al. Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells. Cancer Lett. 2011; 310: 222-231. doi: 10.1016/j.canlet.2011.07.005 PMID: 21803487